Incidence of adverse events during 48Â hours | ||||
---|---|---|---|---|
Adverse events | Control No. (%) | Ketorolac No. (%) | Parecoxib No. (%) | P |
Dyspepsia | 2 (8.7) | 2 (8.7) | 0 (0) | 0.541 |
Nausea/vomiting | 10 (31.2) | 12 (37.5) | 11 (34.4) | 0.871 |
Constipation | 2 (6.2) | 1 (3.1) | 2 (6.2) | 1 |
Dizziness | 5 (15.6) | 8 (25) | 6 (18.8) | 0.632 |
Pruritus | 2 (6.2) | 2 (6.2) | 5 (15.6) | 0.496 |